A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease
| Autor: | Farbman, Eric S., Waters, Cheryl H., LeWitt, Peter A., Rudzińska, Monika, Klingler, Michael, Lee, Angela, Qian, Jenny, Oh, Charles, Hauser, Robert A. |
|---|---|
| Zdroj: | In Parkinsonism and Related Disorders December 2020 81:144-150 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect